Education
About Us
Working with TipRanks
Follow Us
RHON-KLINIKUM AG (GB:0NQH)
LSE:0NQH
Total Valuation
RHON-KLINIKUM AG has a market cap or net worth of €789.87M. The enterprise value is €633.72M.
Market Cap€789.87M
Enterprise Value€633.72M
Share Statistics
RHON-KLINIKUM AG has 66,962,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,962,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RHON-KLINIKUM AG’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 2.61%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)2.61%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee84.79K
Profits Per Employee2.40K
Employee Count18,819
Asset Turnover0.86
Inventory Turnover38.01
Valuation Ratios
The current PE Ratio of RHON-KLINIKUM AG is 22.0. RHON-KLINIKUM AG’s PEG ratio is ―.
PE Ratio22.0
PS Ratio―
PB Ratio―
Price to Fair Value0.72
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, RHON-KLINIKUM AG had revenue of 1.60B and earned 43.35M in profits. Earnings per share was 0.65.
Revenue1.60B
Gross Profit171.82M
Operating Income48.15M
Pretax Income56.20M
Net Income43.35M
EBITDA122.23M
Earnings Per Share (EPS)0.65
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
RHON-KLINIKUM AG pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.21
52-Week Price Change5.98%
50-Day Moving Average12.02
200-Day Moving Average13.21
Relative Strength Index (RSI)65.76
Average Volume (3m)2.00
Important Dates
RHON-KLINIKUM AG upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
RHON-KLINIKUM AG as a current ratio of 2.23, with Debt / Equity ratio of 0.00%
Current Ratio2.23
Quick Ratio2.14
Debt to Market Cap0.15
Net Debt to EBITDA-1.07
Interest Coverage Ratio14.16
Taxes
In the past 12 months, RHON-KLINIKUM AG has paid 11.00M in taxes.
Income Tax11.00M
Effective Tax Rate0.20
Enterprise Valuation
RHON-KLINIKUM AG EV to EBITDA ratio is 6.55, with an EV/FCF ratio of 13.99.
EV to Sales0.50
EV to EBITDA6.55
EV to Free Cash Flow13.99
EV to Operating Cash Flow6.27
Balance Sheet
RHON-KLINIKUM AG has €619.40M in cash and marketable securities with €143.55M in debt, giving a net cash position of -€475.85M billion.
Cash & Marketable Securities€619.40M
Total Debt€143.55M
Net Cash-€475.85M
Net Cash Per Share-€7.11
Tangible Book Value Per Share€17.21
Margins
Gross margin is 27.83%, with operating margin of 3.02%, and net profit margin of 2.72%.
Gross Margin27.83%
Operating Margin3.02%
Pretax Margin3.52%
Net Profit Margin2.72%
EBITDA Margin7.66%
EBIT Margin3.74%
Analyst Forecast
The average price target for RHON-KLINIKUM AG is €13.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€13.00
Price Target Upside4.84% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―